Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 11, 2026 8-K
SCHEDULE 13G May 8, 2026
424B5 May 8, 2026 424B5
424B5 May 8, 2026 424B5
FWP May 7, 2026 FWP
FWP May 7, 2026 FWP
305B2 May 7, 2026 305B2
424B5 May 6, 2026 424B5
424B5 May 6, 2026 424B5
FWP May 5, 2026 FWP
8-K May 5, 2026 8-K
10-Q May 5, 2026 10-Q
8-K May 5, 2026 8-K
ARS Apr 17, 2026 ARS
DEFA14A Apr 17, 2026 DEFA14A
DEF 14A Apr 17, 2026 DEF 14A
8-K Mar 30, 2026 8-K
SCHEDULE 13G/A Mar 27, 2026
4/A Mar 9, 2026 4/A
4/A Mar 9, 2026 4/A
4/A Mar 9, 2026 4/A
4/A Mar 9, 2026 4/A
4 Mar 4, 2026 4
4 Mar 4, 2026 4
4/A Mar 4, 2026 4/A
← Newer Page 2 of 33 · 815 filings Older →